DMW – Klinischer Fortschritt, Table of Contents Dtsch Med Wochenschr 2012; 137(31/32): 1582-1585DOI: 10.1055/s-0032-1305170 Verdauungs- und Stoffwechselkrankheiten | Commentary Gastroenterologie, Stoffwechselkrankheiten © Georg Thieme Verlag KG Stuttgart · New York Hepatische Enzephalopathie Hepatic encephalopathy G. Kircheis 1 Klinik für Gastroenterologie, Hepatologie und Infektionskrankheiten, Heinrich-Heine-Universität Düsseldorf , D. Häussinger 1 Klinik für Gastroenterologie, Hepatologie und Infektionskrankheiten, Heinrich-Heine-Universität Düsseldorf › Author Affiliations Recommend Article Abstract Buy Article Schlüsselwörter Schlüsselwörterhepatische Enzephalopathie - Flimmerfrequenzanalyse - Laktulose - Rifaximin Keywords Keywordshepatic encephalopathy - flicker frequency analysis - lactulose - rifaximin Full Text References Literatur 1 Agusti A, Cauli O, Rodrigo R et al. p38 MAP kinase is a therapeutic target for hepatic encephalopathy in rats with portacaval shunts. Gut 2011; 60: 1572-1579 2 Amodio P, Ridola L, Schiff S et al. Improving the inhibitory control task to detect minimal hepatic encephalopathy. Gastroenterology 2010; 139: 510-518 3 Bajaj J, Hafeezullah M, Franco J et al. Inhibitory control test for the diagnosis of minimal hepatic encephalopathy. Gastroenterology 2008; 135: 1591-1600 4 Bajaj JS, Hafeezullah M, Hoffmann RG et al. Navigation skill impairment: Another dimension of the driving difficulties in minimal hepatic encephalopathy. Hepatology 2008; 47: 596-604 5 Bajaj JS, Schubert CM, Heuman DM et al. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology 2010; 138: 2332-2340 6 Bass NM, Mullen KD, Sanyal A et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med 2010; 362: 1071-1081 7 Biecker E, Hausdörfer I, Grünhage F et al. Critical flicker frequency as a marker of hepatic encephalopathy in patients before and after transjugular intrahepatic portosystemic shunt. Digestion 2011; 83: 24-31 8 Brück J, Görg B, Bidmon HJ et al. Locomotor impairment and cerebrocortical oxidative stress in portal vein ligated rats in vivo. J Hepatol 2011; 54: 251-257 9 Butz M, Timmermann L, Braun M et al. Motor impairment in liver cirrhosis without and with minimal hepatic encephalopathy. Acta Neurol Scand 2010; 122: 27-35 10 Cabral CM, Burns DL. Low-protein diets for hepatic encephalopathy debunked: let them eat steak. Nutr Clin Pract 2011; 26: 155-159 11 Görg B, Qvartskhava N, Bidmon HJ et al. Oxidative stress markers in the brain of patients with cirrhosis and hepatic encephalopathy. Hepatology 2010; 52: 256-265 12 Häussinger D, Cordoba J, Kircheis G et al. Definition and assessment of low-grade hepatic encephalopathy. In: Häussinger D, Kircheis G, Schliess F. Hepatic encephalopathy and nitrogen metabolism. Dordrecht: Springer; 2006: 423-432 13 Holecek M, Kandar R, Sispera L et al. Acute hyperammonemia activates branched-chain amino acid catabolism and decreases their extracellular concentrations: different sensitivity of red and white muscle. Amino Acids 2011; 40: 575-584 14 Kahlbrock N, Butz M, May ES et al. Lowered frequency and impaired modulation of gamma band oscillations in a bimodal attention task are associated with reduced critical flicker frequency. NeuroImage 2012; 61: 216-227 15 Keitel V, Görg B, Bidmon HJ et al. The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain. Glia 2010; 58: 1794-1805 16 Kircheis G, Knoche A, Hilger N et al. Hepatic encephalopathy and fitness to drive. Gastroenterology 2009; 137: 1706-1715 17 McGee RG, Bakens A, Wiley K et al. Probiotics for patients with hepatic encephalopathy. . Cochrane Database Syst Rev 2011; 11 CD008716 18 Pereg D, Kotliroff A, Gadoth N et al. Probiotics for patients with compensated liver cirrhosis: a double-blind placebo-controlled study. Nutrition 2011; 27: 177-81 19 Riggio O, Ridola L, Pasquale C et al. A simplified psychometric evaluation for the diagnosis of minimal hepatic encephalopathy. Clin Gastroenterol Hepatol 2011; 9: 613-616 20 Romero-Gómez M, Córdoba J, Jover R et al. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 2007; 45: 879-885 21 Sharma BC, Sharma P, Agrawal A et al. Secondary prophylaxis of hepatic encephalopathy: An open-label randomized controlled trial of lactulose versus placebo. Gastroenterology 2009; 137: 885-891 22 Sharma P, Agrawal A, Sharma BC et al. Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose versus no lactulose. J Gastroenterol Hepatol 2011; 26: 996-1003 23 Sharma P, Sharma BC, Sarin SK. Critical flicker frequency for diagnosis and assessment of recovery from minimal hepatic encephalopathy in patients with cirrhosis. Hepatobiliary Pancreat Dis Int 2010; 9: 27-32 24 Sharma P, Sharma BC. Rifaximin treatment in hepatic encephalopathy. N Engl J Med 2010; 362: 2423-2424 25 Timmermann L, Gross J, Butz M et al. Mini-asterixis in hepatic encephalopathy induced by pathologic thalamo-motor-cortical coupling. Neurology 2003; 61: 689-692
